| scholarly article | Q13442814 |
| P50 | author | Stephen J White | Q43373154 |
| Jason Lee Johnson | Q43990039 | ||
| Helen Williams | Q63620267 | ||
| P2093 | author name string | Christopher L Jackson | |
| Sarah J George | |||
| P2860 | cites work | A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions | Q24294366 |
| MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation | Q82284786 | ||
| Pathology of the vulnerable plaque | Q83187650 | ||
| Apolipoprotein C-II is a novel substrate for matrix metalloproteinases | Q28284044 | ||
| Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14. | Q33355065 | ||
| ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. | Q33878896 | ||
| Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries | Q34098485 | ||
| Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression | Q35070765 | ||
| N-cadherin-mediated human granulosa cell adhesion prevents apoptosis: a role in follicular atresia and luteolysis? | Q35786965 | ||
| Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme | Q35796049 | ||
| Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases | Q36882797 | ||
| Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme | Q37362401 | ||
| N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. | Q38807097 | ||
| Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability | Q39999043 | ||
| ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells | Q40323023 | ||
| Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases | Q40446304 | ||
| The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells | Q40694935 | ||
| Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion | Q40740891 | ||
| Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. | Q40838158 | ||
| Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices | Q43600816 | ||
| Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein. | Q43740465 | ||
| Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. | Q43974040 | ||
| Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. | Q44157813 | ||
| Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis | Q44523735 | ||
| Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway | Q44680897 | ||
| Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. | Q45003769 | ||
| Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. | Q45938289 | ||
| Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein | Q46471567 | ||
| Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation | Q47875422 | ||
| Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. | Q52544292 | ||
| Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. | Q52548882 | ||
| N-cadherin-dependent cell-cell contacts promote human saphenous vein smooth muscle cell survival. | Q52563236 | ||
| Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. | Q53606830 | ||
| Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients | Q57607763 | ||
| The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis | Q59276652 | ||
| Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis | Q64377816 | ||
| Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer | Q64378618 | ||
| The association of platelet-derived growth factor receptor expression, plaque morphology and histological features with symptoms in carotid atherosclerosis | Q73593128 | ||
| Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability | Q77792632 | ||
| Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors | Q80344477 | ||
| P433 | issue | 1 | |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 137-146 | |
| P577 | publication date | 2010-02-05 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis | |
| P478 | volume | 87 |
| Q26796243 | Activity dependent CAM cleavage and neurotransmission |
| Q38317205 | Advances in non-invasive drug delivery for atherosclerotic heart disease. |
| Q47151616 | Aneurysm Severity is Increased by Combined Mmp-7 Deletion and N-cadherin Mimetic (EC4-Fc) Over-Expression |
| Q90369276 | Animal models of emphysema |
| Q38814461 | Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells |
| Q54361733 | Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese population. |
| Q51100003 | CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo. |
| Q48221411 | Chondroitin sulfate-mediated N-cadherin/β-catenin signaling is associated with basal-like breast cancer cell invasion. |
| Q92024838 | Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction |
| Q53581447 | Content of circulating extracellular DNA, plasma activities of matrix metalloproteinases, and ultrastructure of the myocardium in hypothyroid rats with hypercholesterolemia. |
| Q36496342 | Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion |
| Q34550214 | Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation |
| Q38232998 | Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis |
| Q50077490 | FOXO3a (Forkhead Transcription Factor O Subfamily Member 3a) Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis, and Vascular Remodeling Through a Novel Pathway Involving MMP13 (Matrix Metalloproteinase 13). |
| Q36309887 | Hsp27 as a marker of cell damage in children on chronic dialysis |
| Q35120692 | Identification of candidate genes involved in coronary artery calcification by transcriptome sequencing of cell lines |
| Q51748247 | MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy. |
| Q92757440 | Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels |
| Q37439428 | Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis |
| Q37708436 | Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation |
| Q38010499 | Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine |
| Q37983293 | Matrix metalloproteinase inhibition therapy for vascular diseases |
| Q91259885 | Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
| Q34689554 | Matrix metalloproteinases, synaptic injury, and multiple sclerosis |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q38871902 | Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability |
| Q36527841 | New markers of apoptosis in children on chronic dialysis |
| Q38040358 | Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke |
| Q54518151 | Structural changes in the myocardium and serum lipid spectrum in experimental hypercholesterolemia and hypothyroidism. |
| Q37998958 | The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles |
| Q33999325 | Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis |
| Q33559001 | Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes |
| Q26849336 | Wnt signalling in smooth muscle cells and its role in cardiovascular disorders |
Search more.